
Dr Colin Chu
MA (Cantab), BM BCh, PhD
Current positions
Clinical Senior Research Fellow
Bristol Medical School (THS)
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Research interests
I am a clinical academic and ophthalmologist with research interests in Uveitis and Glaucoma. My current research focuses upon gene therapy for Glaucoma, immunology, in vivo immune cell imaging, advanced methods for tissue analysis and experimental models of ocular inflammation.
Projects and supervisions
Research projects
CLOSED 8064 EBI MRC CiC - Dr Colin Chu
Principal Investigator
Managing organisational unit
Bristol Medical SchoolDates
16/11/2018 to 15/05/2019
Viral Gene Therapy for Glaucoma using CRISPR-Cas9
Principal Investigator
Managing organisational unit
Bristol Medical School (THS)Dates
01/09/2016 to 31/08/2017
Thesis supervisions
Publications
Selected publications
14/10/2020Label-free imaging of immune cell dynamics in the living retina using adaptive optics
eLife
IBEX
Proceedings of the National Academy of Sciences of the United States of America
Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 disruption using CRISPR-Cas9
Molecular Therapy
Recent publications
09/08/2023Adeno-associated virus gene therapy prevents progression of kidney disease in genetic models of nephrotic syndrome
Science Translational Medicine
Triazole-derivatized near-infrared cyanine dyes enable local functional fluorescent imaging of ocular inflammation
Biosensors and Bioelectronics
Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses
Science Translational Medicine
Gene Therapy of Dominant CRX-Leber Congenital Amaurosis using Patient Stem Cell-Derived Retinal Organoids
Stem Cell Reports
Intraoperative complications and visual outcomes of cataract surgery in diabetes mellitus
American Journal of Ophthalmology